MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

BACKGROUND AND PURPOSE—: This study aimed to assess the efficacy of modafinil, a wakefulness-promoting agent in alleviating post-stroke fatigue ≥3 months after stroke. We hypothesized that 200 mg of modafinil daily for 6 weeks would result in reduced symptoms of fatigue compared with placebo. METHOD...

全面介紹

Na minha lista:
書目詳細資料
發表在:Stroke
Main Authors: Bivard, Andrew, Lillicrap, Thomas, Krishnamurthy, Venkatesh, Holliday, Elizabeth, Attia, John, Pagram, Heather, Nilsson, Michael, Parsons, Mark, Levi, Christopher R.
格式: Artigo
語言:Inglês
出版: Lippincott Williams & Wilkins 2017
主題:
Original Contributions
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404401/
https://ncbi.nlm.nih.gov/pubmed/28404841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.016293
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍